LabStyle Innovations Corp., developer of the Dario™ Blood Glucose Monitoring System, announced today the U.S. Patent and Trademark Office has issued the Company patent #9257038 titled, “Fluids testing apparatus and methods of use.”
The invention addresses mobile, hand held, miniature laboratory systems and testing of fluids including bodily fluids such as blood, urine, saliva, and amniotic fluid, as well as non-bodily fluids for industrial, defense and security applications including environmental and food safety.
About the Dario
The Dario Blood Glucose Monitoring System is intended for the quantitative measurement of glucose (sugar) in fresh capillary whole blood. The Dario is intended for self-testing outside the body (in vitro diagnostic use) by people with diabetes at home to monitor the effectiveness of diabetes control.
The Dario Blood Glucose Monitoring System consists of a device housing that includes a blood glucose meter and lancing device. The system also includes test strips, lancets, control solutions and a mobile application. The Dario meter does not require coding or separate batteries. The Dario meter is powered via the 3.5mm audio headphone jack of the smart mobile device. Users are instructed to insert the test strip into the meter, apply the blood or control solution to the test strip, after which the meter will process the test in approximately six (6) seconds and display the test result on the smart mobile device screen via the mobile application.
The Dario Blood Glucose Monitoring System uses Apple’s iOS smart mobile device technology to view the glucose test results via a mobile application. This application is available for download via the smart mobile device’s application store.
LabStyle Innovations Corp.
www.mydario.com